Detalhe da pesquisa
1.
Pruritus in Hemodialysis Patients: Longitudinal Associations With Clinical and Patient-Reported Outcomes.
Am J Kidney Dis
; 82(6): 666-676, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777951
2.
Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation.
Nephrol Dial Transplant
; 35(6): 946-954, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259248
3.
Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure.
Nephrol Dial Transplant
; 35(10): 1689-1699, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33022710
4.
Impact of longer term phosphorus control on cardiovascular mortality in hemodialysis patients using an area under the curve approach: results from the DOPPS.
Nephrol Dial Transplant
; 35(10): 1794-1801, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594171
5.
The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis.
BMC Nephrol
; 21(1): 530, 2020 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33287733
6.
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
Nephrol Dial Transplant
; 34(7): 1163-1170, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29846719
7.
Efficacy and Safety of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in Chinese Dialysis Patients with Hyperphosphataemia: A Randomised, Open-Label, Multicentre, 12-Week Phase III Study.
Nephron
; 148(1): 22-33, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37473746
8.
Safety and Effectiveness of Difelikefalin in Patients With Moderate-to-Severe Pruritus Undergoing Hemodialysis: An Open-Label, Multicenter Study.
Kidney Med
; 4(10): 100542, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36185706
9.
Utility of a Single Itch-Related Question and the Skindex-10 Questionnaire for Assessing Pruritus and Predicting Health-Related Quality of Life in Patients Receiving Hemodialysis.
Kidney Med
; 4(6): 100476, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35651592
10.
Estimating hospital inpatient cost-savings with sucroferric oxyhydroxide in patients on chronic hemodialysis in five European countries: a cost analysis.
J Med Econ
; 24(1): 1240-1247, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34761724
11.
European hemodialysis patient satisfaction with phosphate binders is associated with serum phosphorus levels: the Dialysis Outcomes and Practice Patterns Study.
Clin Kidney J
; 14(8): 1886-1893, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34345411
12.
Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study.
Clin Kidney J
; 14(7): 1770-1779, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34221384
13.
Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study.
Nephron
; 144(9): 428-439, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32585670
14.
Current Practices in CKD-Associated Pruritus: International Nephrologist Survey.
Kidney Int Rep
; 8(7): 1455-1459, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37441482
15.
Long-term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patients.
Hemodial Int
; 22(4): 480-491, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656600
16.
Downregulation of SPARC expression is mediated by nitric oxide in rat mesangial cells and during endotoxemia in the rat.
J Am Soc Nephrol
; 11(3): 468-476, 2000 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-10703670
17.
Biglycan, a nitric oxide-regulated gene, affects adhesion, growth, and survival of mesangial cells.
J Biol Chem
; 278(28): 26227-37, 2003 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-12719420